Arteris, INC Form 4 insider transactions

Paul Alpern, VP and General Counsel of Arteris, Inc., sold shares of common stock on April 2nd and 3rd, 2024, to cover tax liabilities related to the release of restricted stock units.

Arteris, Inc. CEO Charles Janac sold shares of common stock on April 2, 2024, to cover tax liabilities related to the release of restricted stock units.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold shares of common stock on April 2nd and 3rd, 2024, to cover tax liabilities arising from the release of restricted stock units.

Paul Alpern, VP and General Counsel of Arteris, Inc., reports exercising stock options and selling shares under a pre-arranged 10b5-1 trading plan.

Nicholas Hawkins, CFO of Arteris, Inc., sold 10,000 shares of common stock at an average price of $6.9782 on March 11, 2024, under a pre-arranged 10b5-1 trading plan.

Nicholas Hawkins, CFO of Arteris, Inc., sold shares of common stock on March 4th and 5th, 2024, to cover tax liabilities related to the release of restricted stock units.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold a portion of his common stock to cover tax liabilities arising from the release of restricted stock units.

Arteris, Inc. CEO Charles Janac sold shares of common stock on March 4, 2024, to cover tax liabilities and as part of a pre-arranged trading plan.

Paul Alpern, VP and General Counsel of Arteris, Inc., reports the acquisition and disposal of common stock and derivative securities, including transactions made under a 10b5-1 trading plan.

Charles Janac, President and CEO of Arteris, Inc., reports the disposition of 8,534 shares of common stock as a gift and updates beneficial ownership.